デフォルト表紙
市場調査レポート
商品コード
1148796

世界の新生児疾患検診市場:考察と予測 (2028年まで)

Global Newborn Disease Screening Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 93 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
世界の新生児疾患検診市場:考察と予測 (2028年まで)
出版日: 2022年11月07日
発行: QYResearch
ページ情報: 英文 93 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、新生児疾患検診 (Newborn Disease Screening) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の新生児疾患検診の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Hypothyroidism
    • Phenylketonuria
    • Galactosemia
    • Sickle Cell Disease
    • Others
  • 市場:用途別
    • 世界の新生児疾患検診の市場規模成長率:用途別, 2017 VS 2021 VS 2028
    • General Hospitals
    • Specialty Clinics
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の新生児疾患検診の市場展望 (2017-2028)
  • 新生児疾患検診の市場成長トレンド:地域別
    • 新生児疾患検診 市場規模:地域別: 2017 VS 2021 VS 2028
    • 新生児疾患検診の市場規模実績:地域別 (2017-2022)
    • 新生児疾患検診の市場規模予測:地域別 (2023-2028)
  • 新生児疾患検診 市場動向
    • 新生児疾患検診 業界動向
    • 新生児疾患検診 市場の促進要因
    • 新生児疾患検診 市場の課題
    • 新生児疾患検診 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界のトップ 新生児疾患検診の上位企業:収益別
    • 世界のトップ 新生児疾患検診の上位企業:収益別 (2017-2022)
    • 世界の新生児疾患検診の収益シェア:企業別 (2017-2022)
  • 世界の新生児疾患検診の市場シェア:企業タイプ別 (Tier 1, Tier 2, ・ Tier 3)
  • 企業ランキング:新生児疾患検診の収益
  • 世界の新生児疾患検診 市場集中度
    • 世界の新生児疾患検診 市場集中度 (CR5 ・ HHI)
    • 世界の上位10・上位5企業: 新生児疾患検診の収益 2021
  • 新生児疾患検診の主要企業の本社および事業エリア
  • 主要企業 新生児疾患検診の製品ソリューションおよびサービス
  • 市場参入時期: 新生児疾患検診 市場
  • M&A, 拡張計画

第4章 新生児疾患検診 内訳データ:タイプ別

  • 世界の新生児疾患検診の市場規模実績:タイプ別 (2017-2022)
  • 世界の新生児疾患検診の市場規模予測:タイプ別 (2023-2028)

第5章 新生児疾患検診 内訳データ:用途別

  • 世界の新生児疾患検診の市場規模実績:用途別 (2017-2022)
  • 世界の新生児疾患検診の市場規模予測:用途別 (2023-2028)

第6章 北米

  • 北米の新生児疾患検診 市場規模 (2017-2028)
  • 北米の新生児疾患検診 市場規模:タイプ別
    • 北米の新生児疾患検診 市場規模:タイプ別 (2017-2022)
    • 北米の新生児疾患検診 市場規模:タイプ別 (2023-2028)
    • 北米の新生児疾患検診の市場シェア:タイプ別 (2017-2028)
  • 北米の新生児疾患検診 市場規模:用途別
    • 北米の新生児疾患検診 市場規模:用途別 (2017-2022)
    • 北米の新生児疾患検診 市場規模:用途別 (2023-2028)
    • 北米の新生児疾患検診の市場シェア:用途別 (2017-2028)
  • 北米の新生児疾患検診 市場規模:国別
    • 北米の新生児疾患検診 市場規模:国別 (2017-2022)
    • 北米の新生児疾患検診 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の新生児疾患検診 市場規模 (2017-2028)
  • 欧州の新生児疾患検診 市場規模:タイプ別
    • 欧州の新生児疾患検診 市場規模:タイプ別 (2017-2022)
    • 欧州の新生児疾患検診 市場規模:タイプ別 (2023-2028)
    • 欧州の新生児疾患検診の市場シェア:タイプ別 (2017-2028)
  • 欧州の新生児疾患検診 市場規模:用途別
    • 欧州の新生児疾患検診 市場規模:用途別 (2017-2022)
    • 欧州の新生児疾患検診 市場規模:用途別 (2023-2028)
    • 欧州の新生児疾患検診の市場シェア:用途別 (2017-2028)
  • 欧州の新生児疾患検診 市場規模:国別
    • 欧州の新生児疾患検診 市場規模:国別 (2017-2022)
    • 欧州の新生児疾患検診 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 新生児疾患検診 市場規模 (2017-2028)
  • アジア太平洋地域 新生児疾患検診 市場規模:タイプ別
    • アジア太平洋地域 新生児疾患検診 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 新生児疾患検診 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 新生児疾患検診の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 新生児疾患検診 市場規模:用途別
    • アジア太平洋地域 新生児疾患検診 市場規模:用途別 (2017-2022)
    • アジア太平洋地域 新生児疾患検診 市場規模:用途別 (2023-2028)
    • アジア太平洋地域 新生児疾患検診の市場シェア:用途別 (2017-2028)
  • アジア太平洋地域 新生児疾患検診 市場規模:地域別
    • アジア太平洋地域 新生児疾患検診 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 新生児疾患検診 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの新生児疾患検診 市場規模 (2017-2028)
  • ラテンアメリカの新生児疾患検診 市場規模:タイプ別
    • ラテンアメリカの新生児疾患検診 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカの新生児疾患検診 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカの新生児疾患検診の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカの新生児疾患検診 市場規模:用途別
    • ラテンアメリカの新生児疾患検診 市場規模:用途別 (2017-2022)
    • ラテンアメリカの新生児疾患検診 市場規模:用途別 (2023-2028)
    • ラテンアメリカの新生児疾患検診の市場シェア:用途別 (2017-2028)
  • ラテンアメリカの新生児疾患検診 市場規模:国別
    • ラテンアメリカの新生児疾患検診 市場規模:国別 (2017-2022)
    • ラテンアメリカの新生児疾患検診 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの新生児疾患検診 市場規模 (2017-2028)
  • 中東・アフリカの新生児疾患検診 市場規模:タイプ別
    • 中東・アフリカの新生児疾患検診 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカの新生児疾患検診 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカの新生児疾患検診の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカの新生児疾患検診 市場規模:用途別
    • 中東・アフリカの新生児疾患検診 市場規模:用途別 (2017-2022)
    • 中東・アフリカの新生児疾患検診 市場規模:用途別 (2023-2028)
    • 中東・アフリカの新生児疾患検診の市場シェア:用途別 (2017-2028)
  • 中東・アフリカの新生児疾患検診 市場規模:国別
    • 中東・アフリカの新生児疾患検診 市場規模:国別 (2017-2022)
    • 中東・アフリカの新生児疾患検診 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • AB Sciex
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Cytiva
  • Masimo
  • Medtronic
  • Natus Medical
  • PerkinElmer
  • Zentech Manufacturing

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Newborn Disease Screening Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Hypothyroidism
  • Table 3. Key Players of Phenylketonuria
  • Table 4. Key Players of Galactosemia
  • Table 5. Key Players of Sickle Cell Disease
  • Table 6. Key Players of Others
  • Table 7. Global Newborn Disease Screening Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 8. Global Newborn Disease Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Newborn Disease Screening Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Newborn Disease Screening Market Share by Region (2017-2022)
  • Table 11. Global Newborn Disease Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Newborn Disease Screening Market Share by Region (2023-2028)
  • Table 13. Newborn Disease Screening Market Trends
  • Table 14. Newborn Disease Screening Market Drivers
  • Table 15. Newborn Disease Screening Market Challenges
  • Table 16. Newborn Disease Screening Market Restraints
  • Table 17. Global Newborn Disease Screening Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Newborn Disease Screening Revenue Share by Players (2017-2022)
  • Table 19. Global Top Newborn Disease Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2021)
  • Table 20. Ranking of Global Top Newborn Disease Screening Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Newborn Disease Screening Revenue (CR5 and HHI) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Newborn Disease Screening Product Solution and Service
  • Table 24. Date of Enter into Newborn Disease Screening Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. Global Newborn Disease Screening Revenue Market Share by Type (2017-2022)
  • Table 28. Global Newborn Disease Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. Global Newborn Disease Screening Revenue Market Share by Type (2023-2028)
  • Table 30. Global Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 31. Global Newborn Disease Screening Revenue Share by Application (2017-2022)
  • Table 32. Global Newborn Disease Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. Global Newborn Disease Screening Revenue Share by Application (2023-2028)
  • Table 34. North America Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 35. North America Newborn Disease Screening Market Size by Type (2023-2028) & (US$ Million)
  • Table 36. North America Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 37. North America Newborn Disease Screening Market Size by Application (2023-2028) & (US$ Million)
  • Table 38. North America Newborn Disease Screening Market Size by Country (2017-2022) & (US$ Million)
  • Table 39. North America Newborn Disease Screening Market Size by Country (2023-2028) & (US$ Million)
  • Table 40. Europe Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 41. Europe Newborn Disease Screening Market Size by Type (2023-2028) & (US$ Million)
  • Table 42. Europe Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 43. Europe Newborn Disease Screening Market Size by Application (2023-2028) & (US$ Million)
  • Table 44. Europe Newborn Disease Screening Market Size by Country (2017-2022) & (US$ Million)
  • Table 45. Europe Newborn Disease Screening Market Size by Country (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Newborn Disease Screening Market Size by Type (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Newborn Disease Screening Market Size by Application (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Newborn Disease Screening Market Size by Region (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Newborn Disease Screening Market Size by Region (2023-2028) & (US$ Million)
  • Table 52. Latin America Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 53. Latin America Newborn Disease Screening Market Size by Type (2023-2028) & (US$ Million)
  • Table 54. Latin America Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 55. Latin America Newborn Disease Screening Market Size by Application (2023-2028) & (US$ Million)
  • Table 56. Latin America Newborn Disease Screening Market Size by Country (2017-2022) & (US$ Million)
  • Table 57. Latin America Newborn Disease Screening Market Size by Country (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Newborn Disease Screening Market Size by Type (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Newborn Disease Screening Market Size by Type (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Newborn Disease Screening Market Size by Application (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Newborn Disease Screening Market Size by Application (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Newborn Disease Screening Market Size by Country (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Newborn Disease Screening Market Size by Country (2023-2028) & (US$ Million)
  • Table 64. AB Sciex Company Details
  • Table 65. AB Sciex Business Overview
  • Table 66. AB Sciex Newborn Disease Screening Product
  • Table 67. AB Sciex Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 68. AB Sciex Recent Developments
  • Table 69. Agilent Technologies Company Details
  • Table 70. Agilent Technologies Business Overview
  • Table 71. Agilent Technologies Newborn Disease Screening Product
  • Table 72. Agilent Technologies Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 73. Agilent Technologies Recent Developments
  • Table 74. Bio-Rad Laboratories Company Details
  • Table 75. Bio-Rad Laboratories Business Overview
  • Table 76. Bio-Rad Laboratories Newborn Disease Screening Product
  • Table 77. Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 78. Bio-Rad Laboratories Recent Developments
  • Table 79. Cytiva Company Details
  • Table 80. Cytiva Business Overview
  • Table 81. Cytiva Newborn Disease Screening Product
  • Table 82. Cytiva Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 83. Cytiva Recent Developments
  • Table 84. Masimo Company Details
  • Table 85. Masimo Business Overview
  • Table 86. Masimo Newborn Disease Screening Product
  • Table 87. Masimo Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 88. Masimo Recent Developments
  • Table 89. Medtronic Company Details
  • Table 90. Medtronic Business Overview
  • Table 91. Medtronic Newborn Disease Screening Product
  • Table 92. Medtronic Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 93. Medtronic Recent Developments
  • Table 94. Natus Medical Company Details
  • Table 95. Natus Medical Business Overview
  • Table 96. Natus Medical Newborn Disease Screening Product
  • Table 97. Natus Medical Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 98. Natus Medical Recent Developments
  • Table 99. PerkinElmer Company Details
  • Table 100. PerkinElmer Business Overview
  • Table 101. PerkinElmer Newborn Disease Screening Product
  • Table 102. PerkinElmer Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 103. PerkinElmer Recent Developments
  • Table 104. Zentech Manufacturing Company Details
  • Table 105. Zentech Manufacturing Business Overview
  • Table 106. Zentech Manufacturing Newborn Disease Screening Product
  • Table 107. Zentech Manufacturing Revenue in Newborn Disease Screening Business (2017-2022) & (US$ Million)
  • Table 108. Zentech Manufacturing Recent Developments
  • Table 109. Research Programs/Design for This Report
  • Table 110. Key Data Information from Secondary Sources
  • Table 111. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Newborn Disease Screening Market Share by Type: 2021 VS 2028
  • Figure 2. Hypothyroidism Features
  • Figure 3. Phenylketonuria Features
  • Figure 4. Galactosemia Features
  • Figure 5. Sickle Cell Disease Features
  • Figure 6. Others Features
  • Figure 7. Global Newborn Disease Screening Market Share by Application: 2021 VS 2028
  • Figure 8. General Hospitals Case Studies
  • Figure 9. Specialty Clinics Case Studies
  • Figure 10. Newborn Disease Screening Report Years Considered
  • Figure 11. Global Newborn Disease Screening Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Newborn Disease Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Newborn Disease Screening Market Share by Region: 2021 VS 2028
  • Figure 14. Global Newborn Disease Screening Market Share by Players in 2021
  • Figure 15. Global Top Newborn Disease Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Disease Screening as of 2021)
  • Figure 16. The Top 10 and 5 Players Market Share by Newborn Disease Screening Revenue in 2021
  • Figure 17. North America Newborn Disease Screening Market Size YoY (2017-2028) & (US$ Million)
  • Figure 18. North America Newborn Disease Screening Market Size Market Share by Type (2017-2028)
  • Figure 19. North America Newborn Disease Screening Market Size Market Share by Application (2017-2028)
  • Figure 20. North America Newborn Disease Screening Market Size Share by Country (2017-2028)
  • Figure 21. United States Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe Newborn Disease Screening Market Size YoY (2017-2028) & (US$ Million)
  • Figure 24. Europe Newborn Disease Screening Market Size Market Share by Type (2017-2028)
  • Figure 25. Europe Newborn Disease Screening Market Size Market Share by Application (2017-2028)
  • Figure 26. Europe Newborn Disease Screening Market Size Share by Country (2017-2028)
  • Figure 27. Germany Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Russia Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Nordic Countries Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Asia-Pacific Newborn Disease Screening Market Size YoY (2017-2028) & (US$ Million)
  • Figure 34. Asia Pacific Newborn Disease Screening Market Size Market Share by Type (2017-2028)
  • Figure 35. Asia Pacific Newborn Disease Screening Market Size Market Share by Application (2017-2028)
  • Figure 36. Asia Pacific Newborn Disease Screening Market Size Share by Region (2017-2028)
  • Figure 37. China Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Japan Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South Korea Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Southeast Asia Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. India Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Australia Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Latin America Newborn Disease Screening Market Size YoY (2017-2028) & (US$ Million)
  • Figure 44. Latin America Newborn Disease Screening Market Size Market Share by Type (2017-2028)
  • Figure 45. Latin America Newborn Disease Screening Market Size Market Share by Application (2017-2028)
  • Figure 46. Latin America Newborn Disease Screening Market Size Share by Country (2017-2028)
  • Figure 47. Mexico Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Brazil Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Newborn Disease Screening Market Size YoY (2017-2028) & (US$ Million)
  • Figure 50. Middle East and Africa Newborn Disease Screening Market Size Market Share by Type (2017-2028)
  • Figure 51. Middle East and Africa Newborn Disease Screening Market Size Market Share by Application (2017-2028)
  • Figure 52. Middle East and Africa Newborn Disease Screening Market Size Share by Country (2017-2028)
  • Figure 53. Turkey Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Saudi Arabia Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. UAE Newborn Disease Screening Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. AB Sciex Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 57. Agilent Technologies Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 59. Cytiva Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 60. Masimo Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 61. Medtronic Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 62. Natus Medical Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 63. PerkinElmer Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 64. Zentech Manufacturing Revenue Growth Rate in Newborn Disease Screening Business (2017-2022)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed
目次

This research report focuses on the Newborn Disease Screening Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Newborn Disease Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Hypothyroidism
    • 1.2.3 Phenylketonuria
    • 1.2.4 Galactosemia
    • 1.2.5 Sickle Cell Disease
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Newborn Disease Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 General Hospitals
    • 1.3.3 Specialty Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Newborn Disease Screening Market Perspective (2017-2028)
  • 2.2 Newborn Disease Screening Growth Trends by Region
    • 2.2.1 Newborn Disease Screening Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Newborn Disease Screening Historic Market Size by Region (2017-2022)
    • 2.2.3 Newborn Disease Screening Forecasted Market Size by Region (2023-2028)
  • 2.3 Newborn Disease Screening Market Dynamics
    • 2.3.1 Newborn Disease Screening Industry Trends
    • 2.3.2 Newborn Disease Screening Market Drivers
    • 2.3.3 Newborn Disease Screening Market Challenges
    • 2.3.4 Newborn Disease Screening Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Newborn Disease Screening Players by Revenue
    • 3.1.1 Global Top Newborn Disease Screening Players by Revenue (2017-2022)
    • 3.1.2 Global Newborn Disease Screening Revenue Market Share by Players (2017-2022)
  • 3.2 Global Newborn Disease Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Newborn Disease Screening Revenue
  • 3.4 Global Newborn Disease Screening Market Concentration Ratio
    • 3.4.1 Global Newborn Disease Screening Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Newborn Disease Screening Revenue in 2021
  • 3.5 Newborn Disease Screening Key Players Head office and Area Served
  • 3.6 Key Players Newborn Disease Screening Product Solution and Service
  • 3.7 Date of Enter into Newborn Disease Screening Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Newborn Disease Screening Breakdown Data by Type

  • 4.1 Global Newborn Disease Screening Historic Market Size by Type (2017-2022)
  • 4.2 Global Newborn Disease Screening Forecasted Market Size by Type (2023-2028)

5 Newborn Disease Screening Breakdown Data by Application

  • 5.1 Global Newborn Disease Screening Historic Market Size by Application (2017-2022)
  • 5.2 Global Newborn Disease Screening Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Newborn Disease Screening Market Size (2017-2028)
  • 6.2 North America Newborn Disease Screening Market Size by Type
    • 6.2.1 North America Newborn Disease Screening Market Size by Type (2017-2022)
    • 6.2.2 North America Newborn Disease Screening Market Size by Type (2023-2028)
    • 6.2.3 North America Newborn Disease Screening Market Share by Type (2017-2028)
  • 6.3 North America Newborn Disease Screening Market Size by Application
    • 6.3.1 North America Newborn Disease Screening Market Size by Application (2017-2022)
    • 6.3.2 North America Newborn Disease Screening Market Size by Application (2023-2028)
    • 6.3.3 North America Newborn Disease Screening Market Share by Application (2017-2028)
  • 6.4 North America Newborn Disease Screening Market Size by Country
    • 6.4.1 North America Newborn Disease Screening Market Size by Country (2017-2022)
    • 6.4.2 North America Newborn Disease Screening Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Newborn Disease Screening Market Size (2017-2028)
  • 7.2 Europe Newborn Disease Screening Market Size by Type
    • 7.2.1 Europe Newborn Disease Screening Market Size by Type (2017-2022)
    • 7.2.2 Europe Newborn Disease Screening Market Size by Type (2023-2028)
    • 7.2.3 Europe Newborn Disease Screening Market Share by Type (2017-2028)
  • 7.3 Europe Newborn Disease Screening Market Size by Application
    • 7.3.1 Europe Newborn Disease Screening Market Size by Application (2017-2022)
    • 7.3.2 Europe Newborn Disease Screening Market Size by Application (2023-2028)
    • 7.3.3 Europe Newborn Disease Screening Market Share by Application (2017-2028)
  • 7.4 Europe Newborn Disease Screening Market Size by Country
    • 7.4.1 Europe Newborn Disease Screening Market Size by Country (2017-2022)
    • 7.4.2 Europe Newborn Disease Screening Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Disease Screening Market Size (2017-2028)
  • 8.2 Asia-Pacific Newborn Disease Screening Market Size by Type
    • 8.2.1 Asia-Pacific Newborn Disease Screening Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Newborn Disease Screening Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Newborn Disease Screening Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Newborn Disease Screening Market Size by Application
    • 8.3.1 Asia-Pacific Newborn Disease Screening Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Newborn Disease Screening Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Newborn Disease Screening Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Newborn Disease Screening Market Size by Region
    • 8.4.1 Asia-Pacific Newborn Disease Screening Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Newborn Disease Screening Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Newborn Disease Screening Market Size (2017-2028)
  • 9.2 Latin America Newborn Disease Screening Market Size by Type
    • 9.2.1 Latin America Newborn Disease Screening Market Size by Type (2017-2022)
    • 9.2.2 Latin America Newborn Disease Screening Market Size by Type (2023-2028)
    • 9.2.3 Latin America Newborn Disease Screening Market Share by Type (2017-2028)
  • 9.3 Latin America Newborn Disease Screening Market Size by Application
    • 9.3.1 Latin America Newborn Disease Screening Market Size by Application (2017-2022)
    • 9.3.2 Latin America Newborn Disease Screening Market Size by Application (2023-2028)
    • 9.3.3 Latin America Newborn Disease Screening Market Share by Application (2017-2028)
  • 9.4 Latin America Newborn Disease Screening Market Size by Country
    • 9.4.1 Latin America Newborn Disease Screening Market Size by Country (2017-2022)
    • 9.4.2 Latin America Newborn Disease Screening Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Disease Screening Market Size (2017-2028)
  • 10.2 Middle East & Africa Newborn Disease Screening Market Size by Type
    • 10.2.1 Middle East & Africa Newborn Disease Screening Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Newborn Disease Screening Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Newborn Disease Screening Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Newborn Disease Screening Market Size by Application
    • 10.3.1 Middle East & Africa Newborn Disease Screening Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Newborn Disease Screening Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Newborn Disease Screening Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Newborn Disease Screening Market Size by Country
    • 10.4.1 Middle East & Africa Newborn Disease Screening Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Newborn Disease Screening Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 AB Sciex
    • 11.1.1 AB Sciex Company Details
    • 11.1.2 AB Sciex Business Overview
    • 11.1.3 AB Sciex Newborn Disease Screening Introduction
    • 11.1.4 AB Sciex Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.1.5 AB Sciex Recent Developments
  • 11.2 Agilent Technologies
    • 11.2.1 Agilent Technologies Company Details
    • 11.2.2 Agilent Technologies Business Overview
    • 11.2.3 Agilent Technologies Newborn Disease Screening Introduction
    • 11.2.4 Agilent Technologies Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.2.5 Agilent Technologies Recent Developments
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Business Overview
    • 11.3.3 Bio-Rad Laboratories Newborn Disease Screening Introduction
    • 11.3.4 Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.3.5 Bio-Rad Laboratories Recent Developments
  • 11.4 Cytiva
    • 11.4.1 Cytiva Company Details
    • 11.4.2 Cytiva Business Overview
    • 11.4.3 Cytiva Newborn Disease Screening Introduction
    • 11.4.4 Cytiva Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.4.5 Cytiva Recent Developments
  • 11.5 Masimo
    • 11.5.1 Masimo Company Details
    • 11.5.2 Masimo Business Overview
    • 11.5.3 Masimo Newborn Disease Screening Introduction
    • 11.5.4 Masimo Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.5.5 Masimo Recent Developments
  • 11.6 Medtronic
    • 11.6.1 Medtronic Company Details
    • 11.6.2 Medtronic Business Overview
    • 11.6.3 Medtronic Newborn Disease Screening Introduction
    • 11.6.4 Medtronic Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.6.5 Medtronic Recent Developments
  • 11.7 Natus Medical
    • 11.7.1 Natus Medical Company Details
    • 11.7.2 Natus Medical Business Overview
    • 11.7.3 Natus Medical Newborn Disease Screening Introduction
    • 11.7.4 Natus Medical Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.7.5 Natus Medical Recent Developments
  • 11.8 PerkinElmer
    • 11.8.1 PerkinElmer Company Details
    • 11.8.2 PerkinElmer Business Overview
    • 11.8.3 PerkinElmer Newborn Disease Screening Introduction
    • 11.8.4 PerkinElmer Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.8.5 PerkinElmer Recent Developments
  • 11.9 Zentech Manufacturing
    • 11.9.1 Zentech Manufacturing Company Details
    • 11.9.2 Zentech Manufacturing Business Overview
    • 11.9.3 Zentech Manufacturing Newborn Disease Screening Introduction
    • 11.9.4 Zentech Manufacturing Revenue in Newborn Disease Screening Business (2017-2022)
    • 11.9.5 Zentech Manufacturing Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer